U.S. Oil Executives Cautiously Optimistic About 2021 By

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
170
U.S. Oil Executives Cautiously Optimistic About 2021

By Irina Slav - Jan 05, 2021

2021-01-05_qut43qdofh.jpg

The worst seems like it’s over for the U.S. oil industry. Yet executives are entering the new year with cautious optimism, the latest Dallas Fed survey of the industry suggests. Despite an improved outlook for oil and gas in the final quarter of 2020, the biggest portion of respondents in the quarterly survey said they only expected a slight increase in capital spending this year after a disastrous 2020 that saw hefty budget cuts.

The cautiously optimistic executives, however, represented a bit over a third of the total, with 14 percent expecting significant further spending reductions. Interestingly, the same percentage of respondents in the Dallas Fed survey said they expected a substantial increase in spending.

These results suggest mixed sentiment in the industry that only just started getting back on its feet, with the Energy Information Administration’s latest weekly report estimating crude oil production at 11 million bpd, down by about 2 million bpd from pre-pandemic levels.

However, that was to be expected. U.S. oil production fell for three of the four quarters of 2020 in response to oil price movements and only started rebounding in the final quarter of the year. Whether the recovery will continue or slow down remains to be seen and very much depends on how prices move from now on.

The key shale oil industry also presents a mixed picture. Some are pessimistic about its future as most producers cannot break even at current prices. Others are optimistic, and there is even a suggestion among observers that the EIA and the industry itself are deliberately being gloomier than they need to be in order to get OPEC+ to continue its production cuts to keep prices higher.

Related: Big Oil’s Renewables Push Will Come At A Cost

While these cuts have helped prices, uncertainty remains because it’s not just production that determines where the industry goes but also demand, which is arguably a much more important factor right now. And when it comes to demand, the future remains highly uncertain, as Forbes’ David Blackmon noted in a recent article.

The pandemic is still raging in the United States, vaccinations are going much slower than planned, and this means that the eagerly awaited return to normal, if it ever happens, will happen later than many hoped, including in the oil and gas industry.

As a result, the industry will likely continue to face the same challenges this year that it had to tackle in 2020. Layoffs will continue, the Dallas Fed noted in its survey, although they will slow down if prices stabilize. There could be more bankruptcies, too, after last year saw 40 exploration and production companies fold, with a combined debt of $54 billion.

If prices continue to improve, however, the outlook will change. Yet there is no consensus on prices in the industry: forecasts by Dallas Fed survey respondents vary between $30 and $70 a barrel for West Texas Intermediate. Of course, this may reflect differences in cautiousness, but it is a fact no one really knows where oil prices would go even a month from now, let alone by the end of the year.

The situation for U.S. oil companies, especially smaller independents, remains challenging. With hundreds of thousands of new Covid-19 cases daily, the return to normal is being delayed, and so is the strong recovery of oil demand in the world’s largest consumer. Yet demand is recovering in Asia, and it is recovering strongly, boosting export opportunities.

In the end, it will again be all about costs and competitiveness, just as it was during the last oil industry crisis. U.S. shale pulled it off last time, with significant help from oilfield service providers—and it ended up leading the boom in U.S. oil production that turned the country into the world’s largest producer. This year will offer the first signs of what is to come later and whether the industry would be able to recover as strongly from this crisis.

By Irina Slav for Oilprice.com

https://oilprice.com/Energy/Energy-General/US...-2021.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading